ACE2 as therapy for pulmonary arterial hypertension: the good outweighs the bad

Eur Respir J. 2018 Jun 21;51(6):1800848. doi: 10.1183/13993003.00848-2018. Print 2018 Jun.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Connective Tissue Diseases
  • Dehydroepiandrosterone
  • Female
  • Heart Diseases
  • Humans
  • Hypertension, Pulmonary*
  • Peptidyl-Dipeptidase A*

Substances

  • Dehydroepiandrosterone
  • Peptidyl-Dipeptidase A